A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia

The Pharmacogenomics Journal
J T CrossC M Ulrich

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to be effective chemopreventive agents for colorectal neoplasia. Polymorphisms in NSAID targets or metabolizing enzymes may affect NSAID efficacy or toxicity. We conducted a literature review to summarize current evidence of gene-drug interactions between NSAID use and polymorphisms in COX1, COX2, ODC, UGT1A6 and CYP2C9 on risk of colorectal neoplasia by searching OVID and PubMed. Of 134 relevant search results, thirteen investigated an interaction. One study reported a significant interaction between NSAID use and the COX1 Pro17Leu polymorphism (P=0.03) whereby the risk reduction associated with NSAID use among homozygous wild-type genotypes was not observed among NSAID users with variant alleles. Recent pharmacodynamic data support the potential for gene-drug interactions for COX1 Pro17Leu. Statistically significant interactions have also been reported for ODC (315G>A), UGT1A6 (Thr181Ala+Arg184Ser or Arg184Ser alone), and CYP2C9 (*2/*3). No statistically significant interactions have been reported for polymorphisms in COX2; however, an interaction with COX2 -765G>C approached significance (P=0.07) in one study. Among seven remaining studies, reported interactions w...Continue Reading

References

Apr 6, 1978·Biochimica Et Biophysica Acta·J JänneA Raina
Nov 1, 1990·The New England Journal of Medicine·A EkbomH O Adami
Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Aug 1, 1988·Journal of Surgical Oncology·H B KooJ J Decosse
Oct 1, 1984·The British Journal of Surgery·A N KingsnorthH M Wallace
Jul 15, 1998·British Journal of Clinical Pharmacology·J O Miners, D J Birkett
Oct 28, 1998·Journal of the National Cancer Institute·M M Taketo
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Aug 31, 2000·Annual Review of Biochemistry·W L SmithR M Garavito
Mar 20, 2002·Nature Reviews. Cancer·R A Gupta, R N Dubois
Apr 20, 2002·Science·Yan ChengGarret A FitzGerald
Aug 23, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·B T ScottG L Long
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Anastasia PapafiliGeoffrey J Laurent
Oct 29, 2002·Human Mutation·Cornelia M UlrichJohn D Potter
Jan 25, 2003·Clinical Pharmacology and Therapeutics·Marc K HalushkaPerry V Halushka
Mar 7, 2003·The New England Journal of Medicine·Robert S SandlerRichard Schilsky
Mar 7, 2003·The New England Journal of Medicine·John A BaronRosalind U van Stolk
Jun 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Maria Elena MartinezEugene W Gerner
Sep 25, 2003·The Journal of Biological Chemistry·Naveen BabbarEugene W Gerner
Mar 3, 2004·The British Journal of Surgery·G J Morris-StiffW A Jurewicz
Jun 3, 2004·British Journal of Cancer·D G CoxUNKNOWN Bellvitge Colorectal Cancer Study Group
Oct 8, 2004·The New England Journal of Medicine·Eric J Topol
Oct 29, 2004·Nature Reviews. Cancer·Eugene W Gerner, Frank L Meyskens
Feb 17, 2005·The New England Journal of Medicine·Robert S BresalierUNKNOWN Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Cornelia M UlrichJeannette Bigler
Mar 17, 2005·Journal of the National Cancer Institute·Andrew T ChanCharles S Fuchs
Apr 15, 2005·Molecular Nutrition & Food Research·Sandra UlrichJürgen M Stein
Apr 22, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gwendolyn E KuehlJeannette Bigler
Sep 10, 2005·Journal of Thrombosis and Haemostasis : JTH·A O MareeD J Fitzgerald

❮ Previous
Next ❯

Citations

Sep 13, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Marco ErreniPaola Allavena
Jan 5, 2011·Nature Reviews. Clinical Oncology·Marianne Berg, Kjetil Søreide
Sep 17, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Elizabeth L BarryJohn A Baron
May 7, 2011·BMC Medical Informatics and Decision Making·Chiquito CrastoDongquan Chen
Sep 3, 2010·The Tohoku Journal of Experimental Medicine·Hui CaoShao-lin Li
Feb 18, 2015·Drug Metabolism Reviews·Jolantha BeyerleCornelia M Ulrich
Apr 9, 2008·Gastroenterology·Nadir Arber, Bernard Levin
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Bernd FrankHermann Brenner
Feb 14, 2013·Genes, Chromosomes & Cancer·Sarah E KleinsteinCornelia M Ulrich
Feb 5, 2014·Cancer Letters·Sarah KrausNadir Arber
Jun 28, 2016·Biochimica Et Biophysica Acta·Paulo MatosPeter Jordan
Sep 25, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah Kraus, Nadir Arber
Sep 3, 2010·The American Journal of Gastroenterology·Christine Cole JohnsonUNKNOWN PLCO Trial Team
Dec 12, 2018·International Journal of Cancer. Journal International Du Cancer·Tian YangEvropi Theodoratou
Jan 10, 2014·Molecular BioSystems·Xiaodong PengSamy O Meroueh
Jun 15, 2013·Journal of the National Cancer Institute·Vikrant V SahasrabuddheKatherine A McGlynn
Aug 19, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nadir Arber
Apr 15, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eman BiltajiCornelia M Ulrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
E M PooleC M Ulrich
The New England Journal of Medicine
Nadir ArberPreSAP Trial Investigators
© 2021 Meta ULC. All rights reserved